A carregar...
AB027. S6-1. Biomarkers in cholangiocarcinoma
Surgery is the mainstay of early-stage cholangiocarcinoma (CCA); chemotherapy and experimental therapies remain the therapeutic cornerstone in unresectable and metastatic CCA. However, there is no biomarker with clinical utility to predict post-operative tumor recurrence and to select patients most...
Na minha lista:
| Publicado no: | Hepatobiliary Surg Nutr |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421228/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB027 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|